NCT01022112View on ClinicalTrials.gov

An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

383

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

TA-7284-Low

TA-7284-Low

DRUG

TA-7284-Low-middle

TA-7284-Low-middle

DRUG

TA-7284-High-middle

TA-7284-High-middle

DRUG

TA-7284-High

TA-7284-High

DRUG

Placebo

Placebo

Trial Locations (6)

Unknown

Research site, Chugoku

Research site, Kanto

Research site, Kinki

Research site, Kyushu

Research site, Shikoku

Research site, Tōhoku

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY